“We live in unprecedented times. We now have the opportunities to build companies that translate the remarkable discoveries of molecular, cellular and structural biology of the past decades into therapeutics based on mechanistic understanding. Accelerator has accepted this challenge with its high standards and talented entrepreneurs.”

David Hirsh, PhD


Dr. David Hirsh has served in academic, entrepreneurial and executive roles for several decades. Dr. Hirsh is a professor in the Department of Biochemistry and Molecular Biophysics in the College of Physicians and Surgeons of Columbia University, where he also served as department chairman and subsequently was appointed Columbia University’s first executive vice president for research. Dr. Hirsh serves as chairman of the board of the New York Structural Biology Center, as a member of the board of directors of the Agouron Institute and as a trustee emeritus of the Rockefeller University. Previously, Dr. Hirsh worked as the Executive Vice President and Director of Research at Synergen Inc., served as the Chairman of Life Sciences Advisory Board at Warburg Pincus LLC., and participated as a Board Member of several biotechnology companies.

Dr. Hirsh received his B.A. from Reed College, and subsequently he earned a Ph.D. in Biochemistry from the Rockefeller University. He completed his postdoctoral fellowship at the Medical Research Council Laboratory of Molecular Biology in Cambridge, England.